Physiological and pathophysiological roles ofAdiponectin receptors and identification of molecular targets for treatment of life-style related diseases
脂联素受体的生理和病理生理作用以及治疗生活方式相关疾病的分子靶标的鉴定
基本信息
- 批准号:18209033
- 负责人:
- 金额:$ 32.28万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Adiponectin plays a central role as an antidiabetic and antiatherogenic adipokine. AdipoR1 and AdipoR2 serve as receptors for adiponectin in vitro, and their reduction in obesity seems to be correlated with reduced adiponectin sensitivity. In this study, we show that adenovirus-mediated expression of AdipoR1 and R2 in the liver of Lepr(-/-) mice increased AMP-activated protein kinase (AMPK) activation and peroxisome proliferator-activated receptor (PPAR)-alpha signaling pathways, respectively. Activation of AMPK reduced gluconeogenesis, whereas expression of the receptors in both cases increased fatty acid oxidation and lead to an amelioration of diabetes. Alternatively, targeted disruption of AdipoR1 resulted in the abrogation of adiponectin-induced AMPK activation, whereas that of AdipoR2 resulted in decreased activity of PPAR-alpha signaling pathways. Simultaneous disruption of both AdipoR1 and R2 abolished adiponectin binding and actions, resulting in increased tissue triglyceride … More content, inflammation and oxidative stress, and thus leading to insulin resistance and marked glucose intolerance. Therefore, AdipoR1 and R2 serve as the predominant receptors for adiponectin in vivo and play important roles in the regulation of glucose and lipid metabolism, inflammation and oxidative stress in vivo (Nat. Med. 13:332, 2007).We next examined the effects of adiponectin in the central nervous system, In this study, we show that adiponectin enhances AMPK activity in the arcuate hypothalamus (ARH) via its receptor AdipoR1 to stimulate food intake; this stimulation of food intake by adiponectin was attenuated by dominant-negative AMPK expression in the ARE Moreover, adiponectin also decreased energy expenditure. Adiponectin-deficient mice showed decreased AMPK phosphorylation in the ARH, decreased food intake, and increased energy expenditure, exhibiting resistance to high-fat-diet-induced obesity. Serum and cerebrospinal fluid levels of Adiponectin (Clin. Chem. 53:1541, 2007) and expression of AdipoR1 in the ARH were increased during fasting and decreased after refeeding. We conclude that adiponectin stimulates food intake and decreases energy expenditure during fasting through its effects in the central nervous system (Cell Metab. 6:55, 2007; FEBS Lett. 582:74, 2008). Less
脂联素作为一种抗糖尿病和抗动脉粥样硬化的脂肪因子发挥着核心作用。AdipoR 1和AdipoR 2在体外作为脂联素的受体,它们在肥胖中的减少似乎与脂联素敏感性的降低相关。在这项研究中,我们发现腺病毒介导的AdipoR 1和R2在Lepr(-/-)小鼠肝脏中的表达分别增加了AMP激活蛋白激酶(AMPK)激活和过氧化物酶体增殖物激活受体(PPAR)-α信号通路。AMPK的激活减少了糖尿病的发生,而在这两种情况下,受体的表达增加了脂肪酸的氧化,并导致糖尿病的改善。或者,AdipoR 1的靶向破坏导致脂联素诱导的AMPK活化的消除,而AdipoR 2的靶向破坏导致PPAR-alpha信号通路的活性降低。同时破坏AdipoR 1和R2可消除脂联素的结合和作用,导致组织甘油三酯增加。 ...更多信息 胰岛素抵抗和明显的葡萄糖耐受不良。因此,AdipoR 1和R2是脂联素在体内的主要受体,在体内糖脂代谢、炎症和氧化应激的调节中发挥重要作用(Nat.Med.13:332,2007)。我们接下来检查了脂联素在中枢神经系统中的作用。在该研究中,我们表明脂联素通过其受体AdipoR 1增强弓状下丘脑(ARH)中的AMPK活性以刺激食物摄入;在ARE中,显性负性AMPK表达减弱了脂联素对食物摄入的刺激。此外,脂联素还降低了能量消耗。脂联素缺乏小鼠ARH中AMPK磷酸化水平降低,食物摄入减少,能量消耗增加,表现出对高脂饮食诱导的肥胖的抵抗力。血清和脑脊液中脂联素水平(Clin.Chem.53:1541,2007)和ARH中AdipoR 1的表达在禁食期间增加,在再喂养后减少。我们得出结论,脂联素通过其在中枢神经系统中的作用在禁食期间刺激食物摄入并降低能量消耗(Cell Metab. 6:55,2007; FEBS Lett. 582:74,2008)。少
项目成果
期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoRI and AdipoR2
脂联素通过其特异性膜受体AdipoRI和AdipoR2抑制胃癌的生长和腹膜转移
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Ishikawa M;Kitayama J;Yamauchi T;Kadowaki T;Maki T;Miyato H;Yamashita H;Nagawa H.
- 通讯作者:Nagawa H.
Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions
- DOI:10.1038/nm1557
- 发表时间:2007-03-01
- 期刊:
- 影响因子:82.9
- 作者:Yamauchi, Toshimasa;Nio, Yasunori;Kadowaki, Takashi
- 通讯作者:Kadowaki, Takashi
The physiological and pathophysiological role of adiponectin and adiponectin receptoiCs in the peripheral tissues and CNS
脂联素和脂联素受体在外周组织和中枢神经系统中的生理和病理生理作用
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Kadowaki T;Yamauchi T;Kubota N.
- 通讯作者:Kubota N.
Adiponectin stimulates AMP-Activated protein kinase in the hypothalamus and increases food intake
- DOI:10.1016/j.cmet.2007.06.003
- 发表时间:2007-07-01
- 期刊:
- 影响因子:29
- 作者:Kubota, Naoto;Yano, Wataru;Kadowaki, Takashi
- 通讯作者:Kadowaki, Takashi
Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoRl and AdipoR2
脂联素通过其特异性膜受体AdipoRl和AdipoR2抑制胃癌的生长和腹膜转移
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Ishikawa M;Kitayama J;Yamauchi T;Kadowaki T;Maki T;Miyato H;Yamashita H;Nagawa H.
- 通讯作者:Nagawa H.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KADOWAKI Takashi其他文献
KADOWAKI Takashi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KADOWAKI Takashi', 18)}}的其他基金
Comprehensive and expansive research of the universal metabolic regulation mechanisms for healthspan
对健康寿命的普遍代谢调节机制进行全面而广泛的研究
- 批准号:
26000012 - 财政年份:2014
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Specially Promoted Research
A comparison between Japanese men and US men with regard to change in abdominal adipose tissue and progression of subclinical atherosclerosis
日本男性和美国男性腹部脂肪组织变化和亚临床动脉粥样硬化进展的比较
- 批准号:
21590688 - 财政年份:2009
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Integrated elucidation of metabolic pathway in the physiology and pathology
生理病理代谢途径的综合阐明
- 批准号:
20229008 - 财政年份:2008
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Physiological and pathophysiological roles and signal transduction of adiponectin receptors
脂联素受体的生理和病理生理作用及信号转导
- 批准号:
16209030 - 财政年份:2004
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
The pathophysiological roles of adiponectin in the regulation of type 2 diabetes, hyperlipidemia and atherosclerosis
脂联素在调节2型糖尿病、高脂血症和动脉粥样硬化中的病理生理作用
- 批准号:
14207045 - 财政年份:2002
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Identification of type 2 diabetes susceptibility genes in the Japanese population by genome mapping and candidate gene approach and functional analysis
通过基因组作图、候选基因方法和功能分析鉴定日本人群中 2 型糖尿病易感基因
- 批准号:
14013008 - 财政年份:2000
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Development of novel diagnostic and therapeutic strategies for obesity and insulin resistance by identification of endogenous PPARγ ligands
通过鉴定内源性 PPARγ 配体开发肥胖和胰岛素抵抗的新型诊断和治疗策略
- 批准号:
12557093 - 财政年份:2000
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The study for molecular mechanisms of obesity, insulin resistance and atherosclerosis in the PPAR gamma deficient mice
PPARγ缺陷小鼠肥胖、胰岛素抵抗和动脉粥样硬化的分子机制研究
- 批准号:
12470225 - 财政年份:2000
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of susceptibility genes for type 2 diabetes in the Japanese using affected sib pair analysis
使用受影响的同胞对分析鉴定日本人 2 型糖尿病的易感基因
- 批准号:
09557078 - 财政年份:1997
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Approach to the pathogenesis of NIDDM using knockout mouse models.
使用基因敲除小鼠模型探讨 NIDDM 的发病机制。
- 批准号:
09470215 - 财政年份:1997
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Understanding the role of adiposity and adipokine-related RNA expression in the tumor microenvironment on breast cancer outcomes in a racially and ethnically diverse sample
了解肿瘤微环境中肥胖和脂肪因子相关 RNA 表达对种族和民族多样化样本中乳腺癌结果的作用
- 批准号:
10602753 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
Adipokine Signaling as a Therapeutically Targetable Driver of Tumor Metabolism
脂肪因子信号传导作为肿瘤代谢的治疗靶向驱动因素
- 批准号:
10366023 - 财政年份:2021
- 资助金额:
$ 32.28万 - 项目类别:
Adipokine Signaling as a Therapeutically Targetable Driver of Tumor Metabolism
脂肪因子信号传导作为肿瘤代谢的治疗靶向驱动因素
- 批准号:
10580769 - 财政年份:2021
- 资助金额:
$ 32.28万 - 项目类别:
Role of Adipokine FABP4 in Glucoregulation and Counter Regulatory Responses
脂肪因子 FABP4 在血糖调节和反调节反应中的作用
- 批准号:
10530591 - 财政年份:2019
- 资助金额:
$ 32.28万 - 项目类别:
Role of Adipokine FABP4 in Glucoregulation and Counter Regulatory Responses
脂肪因子 FABP4 在血糖调节和反调节反应中的作用
- 批准号:
10304199 - 财政年份:2019
- 资助金额:
$ 32.28万 - 项目类别:
A novel adipokine suppresses leptin signaling and promotes obesity
一种新型脂肪因子抑制瘦素信号传导并促进肥胖
- 批准号:
10327290 - 财政年份:2019
- 资助金额:
$ 32.28万 - 项目类别:
Regulation of white fat browning by a novel, brown fat-secreted adipokine
新型棕色脂肪分泌脂肪因子对白色脂肪褐变的调节
- 批准号:
9751849 - 财政年份:2018
- 资助金额:
$ 32.28万 - 项目类别:
adipokine and bladder cancer -new mechanisms of modulating PGE2
脂肪因子与膀胱癌——调节PGE2的新机制
- 批准号:
16K20143 - 财政年份:2016
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Adipokine Modulation of Fibrosis: Novel Scleroderma Pathway
纤维化的脂肪因子调节:硬皮病新途径
- 批准号:
8823417 - 财政年份:2015
- 资助金额:
$ 32.28万 - 项目类别:
Adipokines, adipokine receptors, and disparities in breast cancer clinicopathological features
脂肪因子、脂肪因子受体和乳腺癌临床病理特征的差异
- 批准号:
9124777 - 财政年份:2015
- 资助金额:
$ 32.28万 - 项目类别:














{{item.name}}会员




